Genelux (GNLX) Equity Ratio (2022 - 2026)
Genelux (GNLX) recorded quarterly Equity Ratio of 0.71 in Q1 2026, up 16.7% quarter-over-quarter from 0.61 in Q4 2025.
Genelux (GNLX) Equity Ratio (2022 - 2026) Analysis & Trends
Genelux's Equity Ratio history runs 5 years deep, the most recent figure standing at 0.71 for Q1 2026.
- In Q1 2026, Equity Ratio changed N/A year-over-year to 0.71; the TTM figure through Mar 2026 stood at 0.71 (changed N/A YoY), while the FY2025 annual figure was 0.61, down 19.83% from the prior year.
- Equity Ratio was 0.71 for Q1 2026 at Genelux, up from 0.61 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.83 in Q2 2024 to a low of 6.47 in Q4 2022.
- Historically, Equity Ratio has averaged 0.07 across 5 years, with a median of 0.71 in 2026.
- The sharpest annual moves came in 2023 and 2025: Equity Ratio surged 110.79% in 2023, then dropped 19.83% in 2025.
- A 5-year view of Equity Ratio shows it stood at 6.47 in 2022, then surged by 110.79% to 0.7 in 2023, then grew by 8.41% to 0.76 in 2024, then declined by 19.83% to 0.61 in 2025, then rose by 16.7% to 0.71 in 2026.
- The last three Equity Ratio figures came in at 0.71 (Q1 2026), 0.61 (Q4 2025), and 0.74 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 191.07 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.98 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 0.04 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.42 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.73 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 0.79 |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 0.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.71 |
| Dec 31, 2025 | 0.61 |
| Sep 30, 2025 | 0.74 |
| Jun 30, 2025 | 0.74 |
| Dec 31, 2024 | 0.76 |
| Sep 30, 2024 | 0.82 |
| Jun 30, 2024 | 0.83 |
| Mar 31, 2024 | 0.61 |
| Dec 31, 2023 | 0.70 |
| Sep 30, 2023 | 0.71 |
| Dec 31, 2022 | -6.47 |